New ovarian cancer drug could give women years of life in the form of a ‘therapeutic’ vaccine

Women who have ovarian cancer are to receive a new vaccine that experts hope could give them years of extra life. Survival rates for the disease, which claims more than 4,000 lives a year in Britain, are low because it is often only spotted late, when tumours have spread to the rest of the body. But Canadian company BioVaxys has developed a ‘therapeutic’ vaccine – one to be used as a treatment for those already ill – which it believes could significantly extend lives. It works by teaching the immune system how to recognise cancerous cells, which are adept at hiding themselves to avoid attack.

Each jab is tailored to the individual and uses cancerous cells extracted from the patient’s own tumours after surgery. While European testing involving up to 100 patients is expected to start towards the end of the year, Dr David Berd, who pioneered the method, said the results from a small-scale trial with a prototype vaccine had been promising. ‘Survival was two to three times what one would expect [in women with advanced ovarian cancer].

There were a couple with five-year survival,’ he added. Since that study, he said, the vaccine had been improved and the new version would be capable of giving some women ‘years of extra life’. BioVaxys is working with a Spanish company, Procter & Gamble spin-off Procare Health, to co[1]fund the new trial, but decisions on which countries the trial will take place in have yet to be finalised.

BioVaxys is also developing another vaccine for treating women with cervical cancer and pursuing one to protect those who are infected with certain strains of human papillomavirus (HPV), which over time can trigger cervical and other cancers in some individuals. While ‘prophylactic’ HPV vaccines are now well established, and offered to all boys and girls in the UK when they are 12 or 13 (in school year 8), these vaccines cannot protect anyone who has already been infected with the virus, which is spread through sexual contact

Ultimas noticias

Día Internacional de la Mujer: lucha por la igualdad

El 8 de marzo se celebra el Día Internacional de la Mujer y es la mejor fecha para recordar todos los avances hacia la igualdad conseguidos hasta el momento, pero también -y sobre todo- para visibilizar las desigualdades y poner el foco en lo mucho que todavía queda por conseguir.

Leer más »

Resumen de Privacidad.

PROCARE HEALTH IBERIA SL utiliza cookies propias y de terceros para entender mejor el uso de este sitio web y mejorarlo en base a un perfil elaborado a partir de sus hábitos de navegación. Puede encontrar información detallada sobre el uso de cookies estrictamente necesarias, que
son esenciales para navegar en este sitio web, y cookies opcionales, que puede rechazar o aceptar a continuación, y sobre cómo puede cambiar o revocar su consentimiento en cualquier momento en nuestra Política de Privacidad.

Estas cookies son necesarias para las funciones asenciales tales como la gestion de la seguridad de la red y la accesibilidad. Las cookies estandar no se pueden desasctivar

Informacion de las cookies

Activas siempre

Estas cookies recogen informacion como cuantos usuarios estan utilizando nuestro sitio o que paginas son populares para ayudarnos a mejorar la experiencia del usuario. Si desactivas estas cookies significara que no podemos recoger informacion para mejorar la experiencia.

Informacion de las cookies.

Utilizamos cookies para ofrecerte la mejor experiencia en nuestra web.
Puedes aprender mas sobre cookies utilizamos o desactivamos en los ajustes